Cite
HARVARD Citation
Carvajal, R. et al. (2022). Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of clinical oncology. 40 (17), pp. 1939-1948. [Online].